GM2A

gene product
SAP-3
This gene encodes a small glycolipid transport protein which acts as a substrate specific co-factor for the lysosomal enzyme beta-hexosaminidase A. Beta-hexosaminidase A, together with GM2 ganglioside activator, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene result in GM2-gangliosidosis type AB or the AB variant of Tay-Sachs disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2009]
More gene data

Featured antibodies

Antibodies

 

Filters

Antibodypedia Validation Initiative

Validation method

Application

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
337 antibodies from 29 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeAVIWBELICCIPIHCFC
Atlas Antibodies
1 antibody
NovoPro Bioscience Inc.
8 antibodies
Novus Biologicals
7 antibodies
Antibodies.com
2 antibodies
Proteintech Group
2 antibodies
Bioworld Technology, Inc
1 antibody
antibodies-online
98 antibodies
Biorbyt
20 antibodies
Acris Antibodies GmbH
5 antibodies
Everest Biotech
2 antibodies
NSJ Bioreagents
2 antibodies
Aviva Systems Biology
5 antibodies
LifeSpan BioSciences, Inc.
54 antibodies
Abnova Corporation
9 antibodies
OriGene
8 antibodies
Abgent
6 antibodies
Invitrogen Antibodies
3 antibodies
Creative Biolabs
3 antibodies
St John's Laboratory
4 antibodies
ProSci
6 antibodies
MyBioSource
6 antibodies
GeneTex
1 antibody
Abbexa
3 antibodies
Creative Diagnostics
5 antibodies
Sigma-Aldrich
1 antibody
United States Biological
57 antibodies
RayBiotech, Inc.
4 antibodies
UC Davis/NIH NeuroMab Facility
2 antibodies